Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can we predict stent infections before they happen?

NCT ID NCT07760792

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Sep 02, 2026 · Updated 6 times

Summary

This study follows 300 adults who receive a temporary Double-J ureteral stent for routine urological reasons. Researchers will check the stent and urine for bacteria when the stent is removed, and look for links to factors like how long the stent was in place, diabetes, kidney disease, past infections, and antibiotic use. The goal is to better understand what raises the risk of bacterial colonization and whether it leads to infections or symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help identify patients at higher risk of stent-related infections and guide strategies to prevent them.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply to all patients or stent types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with temporary Double-J ureteral stents placed for routine urological indications and available for follow-up until stent removal.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Temporary Double-J stent insertion. * Standard urological indication. * Planned stent removal during follow-up. * Ability to attend follow-up and provide specimens. * Written informed consent. Exclusion Criteria: * Active urosepsis at insertion. * Permanent or intended long-term stenting. * Concomitant nephrostomy tube or urinary diversion. * Severe immunosuppression or neutropenia. * Incomplete baseline data. * Loss to follow-up or failure to retrieve the stent. * Refusal to participate.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bacterial colonization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Urology, Al-Hussein and Sayed Galal University Hospitals, Al-Azhar University

    RECRUITING

    Cairo, Cairo Governorate, 11633, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.